← Leaderboards
Jing Wang
Cengent Therapeutics, Inc.
$99,688
Attributed
$99,688
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$99,688 · 1
By mechanism
R43$99,688 · 1
Top collaborators
No co-investigators on record.
Most similar at Cengent Therapeutics, Inc.
Same institution · by research overlap
- Martha C Mutomba$481,711
- Hengyi Zhu$640,128
- Christina C Niemeyer$372,652
- Mark D Shenderovich$99,297
Others in their field
Top investigators on “Antineoplastics”
- David Heimbrook · Leidos Biomedical Research, Inc.$245,744,647
- Leonard Freedman · Leidos Biomedical Research, Inc.$243,278,693
- Charles A Coltman · Southwest Oncology Group$134,454,243
- Gregory H Reaman · National Childhood Cancer Foundation$112,139,479
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,166,869
- Richard L Schilsky · University Of Chicago$90,728,118
Research focus
AntineoplasticsBinding SitesBiological Signal TransductionBiomimeticsBiotherapeutic AgentCell ProliferationConformationCytotoxicityDrug Design /Synthesis /ProductionDrug Discovery /IsolationEpidermal Growth FactorExtracellularGrowth Factor ReceptorsInhibitor /AntagonistMolecular DynamicsNuclear Magnetic Resonance SpectroscopyProtein Protein InteractionReceptor Binding